PlainRecalls
FDA Devices Moderate Class II Ongoing

Percept PC BrainSense Implantable Neurostimulator (INS) Model B35200

Reported: June 1, 2022 Initiated: March 30, 2022 #Z-1129-2022

Product Description

Percept PC BrainSense Implantable Neurostimulator (INS) Model B35200

Reason for Recall

The Implantable Neurostimulator (INS) cannot communicate with the clinical programmer and/or the patient programmer system.

Details

Recalling Firm
Medtronic Neuromodulation
Units Affected
1 unit
Distribution
Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and the countries of Argentina, Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand, United Kingdom.
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Percept PC BrainSense Implantable Neurostimulator (INS) Model B35200. Recalled by Medtronic Neuromodulation. Units affected: 1 unit.
Why was this product recalled?
The Implantable Neurostimulator (INS) cannot communicate with the clinical programmer and/or the patient programmer system.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 1, 2022. Severity: Moderate. Recall number: Z-1129-2022.